The U.S. Food and Drug Administration (FDA) has granted Donisi De Novo clearance for its contact-free multiparameter measurement system. The innovative system is backed by 26 patents and consists of a combination of artificial intelligence (AI), algorithms, and proprietary optics to recognize and interpret micro-vibrations on the surface level caused by internal organs remotely. Yair Brosh, CEO of Donisi, stated, “I’m really proud of our team; we developed a medical device that can change the lives of millions of people. Our novel technology is now recognized and cleared by FDA which is a great accomplishment.”
Read more here.
More on: News Regulatory